This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Jinan University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Fei Xiao: Innovator in Neurodegenerative Disease Treatment
Introduction
Fei Xiao is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of medicine, particularly in the treatment of neurodegenerative diseases. His innovative work focuses on the use of natural compounds to promote cellular health and mitigate the effects of debilitating conditions.
Latest Patents
Fei Xiao holds a patent for the "Use of Crassifolin A in preparation of drug for promoting mitophagy and treating neurodegenerative diseases." This invention discloses the potential of Crassifolin A, a diterpene compound, to significantly enhance mitophagy levels. The compound promotes the removal of damaged mitochondria, thereby maintaining cellular homeostasis. It has shown promise in treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier, making it a valuable candidate for therapeutic applications. The compound is derived from a Thickleaf croton root, which is abundant and has low toxicity, presenting a favorable profile for drug development.
Career Highlights
Fei Xiao is affiliated with Jinan University, where he conducts research and develops innovative solutions for health-related challenges. His work has garnered attention for its potential impact on treating neurodegenerative diseases, which affect millions worldwide. His dedication to advancing medical science is evident in his research and patent contributions.
Collaborations
Fei Xiao collaborates with esteemed colleagues, including Yubo Zhang and Guocai Wang. Their combined expertise enhances the research efforts and broadens the scope of their innovative projects.
Conclusion
Fei Xiao's contributions to the field of neurodegenerative disease treatment through his patent on Crassifolin A highlight the importance of natural compounds in modern medicine. His work exemplifies the potential for innovation to improve health outcomes and offers hope for those affected by these challenging conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile